10 Great Books On Pragmatic Free Trial Meta: Difference between revisions

From VSt Wiki
mNo edit summary
mNo edit summary
 
Line 1: Line 1:
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a non-commercial, open data platform and infrastructure that facilitates research on pragmatic trials. It collects and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for a variety of meta-epidemiological analyses that compare treatment effect estimates across trials of various levels of pragmatism.<br><br>Background<br><br>Pragmatic studies are increasingly recognized as providing real-world evidence for clinical decision-making. The term "pragmatic" however, is not used in a consistent manner and its definition and assessment need further clarification. Pragmatic trials are intended to inform clinical practices and policy decisions rather than confirm a physiological hypothesis or clinical hypothesis. A pragmatic trial should try to be as similar to the real-world clinical environment as possible, including in the selection of participants, setting up and design of the intervention, its delivery and execution of the intervention, and the determination and analysis of outcomes and primary analyses. This is a major  [https://techdirt.stream/story.php?title=12-stats-about-free-slot-pragmatic-to-refresh-your-eyes-at-the-cooler-water-cooler 라이브 카지노] difference between explanatory trials as described by Schwartz and Lellouch1 which are designed to test the hypothesis in a more thorough manner.<br><br>Truly pragmatic trials should not conceal participants or the clinicians. This could lead to bias in the estimations of the effect of treatment. Practical trials should also aim to recruit patients from a variety of health care settings so that their results can be applied to the real world.<br><br>Finally studies that are pragmatic should focus on outcomes that are vital for patients, such as quality of life or  [https://www.northwestu.edu/?URL=https://anotepad.com/notes/a5ebh5wn 프라그마틱 데모] functional recovery. This is particularly important in trials that involve invasive procedures or those with potential for serious adverse events. The CRASH trial29 compared a two-page report with an electronic monitoring system for patients in hospitals with chronic heart failure. The trial with a catheter, however utilized symptomatic catheter-related urinary tract infection as its primary outcome.<br><br>In addition to these aspects the pragmatic trial should also reduce the procedures for conducting trials and [http://yd.yichang.cc/home.php?mod=space&uid=827889 프라그마틱 플레이] data collection requirements to reduce costs. Finaly, pragmatic trials should aim to make their results as relevant to real-world clinical practices as they can. This can be accomplished by ensuring that their analysis is based on an intention-to treat approach (as defined in CONSORT extensions).<br><br>Despite these criteria, a number of RCTs with features that defy pragmatism have been incorrectly self-labeled pragmatic and published in journals of all types. This can lead to false claims of pragmaticity and the use of the term must be standardized. The creation of the PRECIS-2 tool, which offers an objective standard for assessing practical features is a great first step.<br><br>Methods<br><br>In a pragmatic study the aim is to inform policy or clinical decisions by demonstrating how an intervention can be integrated into routine treatment in real-world settings. Explanatory trials test hypotheses about the causal-effect relationship in idealized environments. Consequently, pragmatic trials may have lower internal validity than explanatory trials and may be more susceptible to bias in their design, conduct and analysis. Despite these limitations, pragmatic trials can contribute valuable information to decision-making in the context of healthcare.<br><br>The PRECIS-2 tool evaluates the degree of pragmatism in an RCT by scoring it across 9 domains that range from 1 (very explanatory) to 5 (very pragmatic). In this study the areas of recruitment, organisation, flexibility in delivery, flexibility in adherence, and follow-up scored high. However, the primary outcome and method of missing data scored below the pragmatic limit. This suggests that it is possible to design a trial with excellent pragmatic features without harming the quality of the results.<br><br>It is hard to determine the degree of pragmatism that is present in a trial because pragmatism does not have a single attribute. Certain aspects of a study can be more pragmatic than other. A trial's pragmatism can be affected by modifications to the protocol or the logistics during the trial. Koppenaal and colleagues found that 36% of 89 pragmatic studies were placebo-controlled or conducted prior to the licensing. Most were also single-center. They are not in line with the norm and can only be called pragmatic if the sponsors agree that these trials aren't blinded.<br><br>A common aspect of pragmatic research is that researchers attempt to make their findings more meaningful by analyzing subgroups within the trial sample. However, this often leads to unbalanced comparisons and lower statistical power, thereby increasing the chance of not or misinterpreting differences in the primary outcome. In the case of the pragmatic studies included in this meta-analysis this was a major issue since the secondary outcomes were not adjusted to account for variations in the baseline covariates.<br><br>In addition, pragmatic studies can pose difficulties in the gathering and interpretation of safety data. This is because adverse events are typically reported by participants themselves and are susceptible to delays in reporting, inaccuracies or coding errors. It is therefore important to enhance the quality of outcomes assessment in these trials, and ideally by using national registries rather than relying on participants to report adverse events in a trial's own database.<br><br>Results<br><br>Although the definition of pragmatism doesn't require that all clinical trials be 100% pragmatist, there are benefits to including pragmatic components in trials. These include:<br><br>Incorporating routine patients, the trial results are more easily translated into clinical practice. However, [http://demo01.zzart.me/home.php?mod=space&uid=4933814 프라그마틱 슬롯 추천] pragmatic trials can also have drawbacks. For  [https://www.diggerslist.com/66e5da45cfa21/about 프라그마틱 슬롯 추천] instance, the right type of heterogeneity can help a study to generalize its findings to a variety of settings and patients. However the wrong kind of heterogeneity can reduce assay sensitiveness and consequently lessen the ability of a study to detect even minor effects of treatment.<br><br>Several studies have attempted to classify pragmatic trials using different definitions and scoring methods. Schwartz and Lellouch1 developed an approach to distinguish between research studies that prove a clinical or physiological hypothesis as well as pragmatic trials that help in the selection of appropriate treatments in real-world clinical practice. Their framework comprised nine domains, each scoring on a scale ranging from 1-5, with 1 being more informative and 5 suggesting more pragmatic. The domains included recruitment, setting up, delivery of intervention, flex adherence and primary analysis.<br><br>The original PRECIS tool3 included similar domains and an assessment scale ranging from 1 to 5. Koppenaal and colleagues10 created an adaptation of the assessment, called the Pragmascope, that was easier to use for systematic reviews. They found that pragmatic systematic reviews had higher average score in most domains, but lower scores in the primary analysis domain.<br><br>This distinction in the analysis domain that is primary could be due to the fact that most pragmatic trials process their data in an intention to treat way, whereas some explanatory trials do not. The overall score for systematic reviews that were pragmatic was lower when the areas of organisation, flexible delivery and follow-up were merged.<br><br>It is important to remember that the term "pragmatic trial" does not necessarily mean a low-quality trial, and in fact there is a growing number of clinical trials (as defined by MEDLINE search, but this is neither sensitive nor specific) that employ the term "pragmatic" in their abstract or title. The use of these words in abstracts and titles may suggest a greater awareness of the importance of pragmatism, but it is unclear whether this is manifested in the content of the articles.<br><br>Conclusions<br><br>In recent times, pragmatic trials are increasing in popularity in research because the importance of real-world evidence is increasingly recognized. They are randomized trials that compare real world care alternatives to experimental treatments in development. They are conducted with populations of patients that are more similar to those who receive treatment in regular care. This method can help overcome the limitations of observational research, for example, the biases associated with the use of volunteers as well as the insufficient availability and the coding differences in national registry.<br><br>Other advantages of pragmatic trials include the possibility of using existing data sources,  [http://firewar888.tw/home.php?mod=space&uid=1281001 프라그마틱 플레이] as well as a higher chance of detecting meaningful changes than traditional trials. However, pragmatic tests may still have limitations which undermine their reliability and generalizability. For example, participation rates in some trials may be lower than expected due to the healthy-volunteer effect as well as incentives to pay or compete for participants from other research studies (e.g. industry trials). A lot of pragmatic trials are restricted by the need to enroll participants on time. Certain pragmatic trials lack controls to ensure that the observed variations aren't due to biases that occur during the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified 48 RCTs self-labeled as pragmatist and published until 2022. The PRECIS-2 tool was employed to determine pragmatism. It includes areas such as eligibility criteria as well as recruitment flexibility and adherence to intervention and follow-up. They discovered that 14 of the trials scored as highly or pragmatic sensible (i.e. scoring 5 or more) in any one or more of these domains, and that the majority were single-center.<br><br>Trials with a high pragmatism rating tend to have broader eligibility criteria than traditional RCTs, which include very specific criteria that are unlikely to be present in the clinical environment, and they contain patients from a broad variety of hospitals. According to the authors, could make pragmatic trials more useful and applicable in everyday practice. However they do not ensure that a study is free of bias. The pragmatism is not a fixed attribute; a pragmatic test that doesn't have all the characteristics of an explanatory study can still produce valuable and valid results.
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trial Meta is a free and non-commercial open data platform and infrastructure that supports research on pragmatic trials. It collects and distributes cleaned trial data, [https://bookmarkusers.com/story18148945/this-is-the-pragmatic-site-case-study-you-ll-never-forget 프라그마틱 사이트] 슬롯, [https://myfirstbookmark.com/story18338578/15-reasons-you-must-love-pragmatic-image mouse click the up coming internet site], ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that compare treatment effect estimates across trials of different levels of pragmatism.<br><br>Background<br><br>Pragmatic studies provide real-world evidence that can be used to make clinical decisions. However, the use of the term "pragmatic" is not consistent and its definition and assessment requires further clarification. Pragmatic trials must be designed to guide clinical practice and policy decisions, rather than confirm a physiological or clinical hypothesis. A pragmatic trial should aim to be as close as is possible to the real-world clinical practice which include the recruitment of participants, setting, designing, delivery and execution of interventions, determining and analysis results, as well as primary analysis. This is a significant difference between explanation-based trials, as defined by Schwartz and Lellouch1 which are designed to confirm a hypothesis in a more thorough way.<br><br>Trials that are truly practical should not attempt to blind participants or the clinicians, as this may lead to bias in estimates of treatment effects. The trials that are pragmatic should also try to enroll patients from a wide range of health care settings, so that their results can be applied to the real world.<br><br>Finally the focus of pragmatic trials should be on outcomes that are important to patients, such as quality of life or functional recovery. This is particularly relevant when trials involve surgical procedures that are invasive or may have harmful adverse consequences. The CRASH trial29, for instance was focused on functional outcomes to compare a two-page report with an electronic system for the monitoring of hospitalized patients with chronic heart failure. In addition, the catheter trial28 focused on urinary tract infections that are symptomatic of catheters as its primary outcome.<br><br>In addition to these characteristics, pragmatic trials should minimize the trial procedures and data collection requirements in order to reduce costs. Additionally, pragmatic trials should aim to make their results as applicable to current clinical practices as they can. This can be achieved by ensuring that their analysis is based on the intention to treat method (as described within CONSORT extensions).<br><br>Many RCTs that do not meet the criteria for pragmatism but contain features contrary to pragmatism, have been published in journals of different types and incorrectly labeled pragmatic. This can lead to false claims of pragmatism, and the usage of the term should be standardized. The creation of the PRECIS-2 tool, which offers an objective and standard assessment of pragmatic features, is a good first step.<br><br>Methods<br><br>In a practical trial the goal is to inform policy or clinical decisions by demonstrating how the intervention can be implemented into routine care. Explanatory trials test hypotheses about the causal-effect relationship in idealized settings. In this way, pragmatic trials may have a lower internal validity than studies that explain and be more susceptible to biases in their design, analysis, and conduct. Despite these limitations, pragmatic trials can be a valuable source of information for decision-making in the context of healthcare.<br><br>The PRECIS-2 tool scores an RCT on 9 domains, ranging between 1 and 5 (very pragmatist). In this study, the domains of recruitment, organisation, flexibility in delivery, flexibility in adherence, and follow-up scored high. However, the main outcome and the method of missing data was scored below the pragmatic limit. This suggests that a trial could be designed with effective practical features, but without harming the quality of the trial.<br><br>However, it's difficult to judge how practical a particular trial is, since the pragmatism score is not a binary quality; certain aspects of a trial may be more pragmatic than others. Furthermore, logistical or protocol modifications made during a trial can change its score on pragmatism. Additionally 36% of 89 pragmatic trials discovered by Koppenaal and colleagues were placebo-controlled or conducted prior to approval and a majority of them were single-center. They are not in line with the usual practice and are only called pragmatic if their sponsors agree that the trials aren't blinded.<br><br>Another common aspect of pragmatic trials is that the researchers attempt to make their findings more meaningful by analysing subgroups of the sample. However, [https://bookmarkpressure.com/story18246026/a-an-instructional-guide-to-pragmatic-demo-from-beginning-to-end 프라그마틱 슬롯체험] this often leads to unbalanced comparisons and lower statistical power, increasing the likelihood of missing or misinterpreting the results of the primary outcome. This was the case in the meta-analysis of pragmatic trials due to the fact that secondary outcomes were not corrected for differences in covariates at the baseline.<br><br>Additionally, studies that are pragmatic can pose difficulties in the collection and interpretation of safety data. This is due to the fact that adverse events are typically reported by participants themselves and prone to reporting errors, delays or coding deviations. It is essential to increase the accuracy and quality of outcomes in these trials.<br><br>Results<br><br>While the definition of pragmatism does not mean that trials must be 100% pragmatic, there are some advantages to incorporating pragmatic components into clinical trials. These include:<br><br>Enhancing sensitivity to issues in the real world as well as reducing the size of studies and their costs and allowing the study results to be more quickly translated into actual clinical practice (by including patients from routine care). However, pragmatic trials have their disadvantages. The right amount of heterogeneity for instance could allow a study to expand its findings to different patients or settings. However the wrong type of heterogeneity could reduce the sensitivity of an assay and thus lessen the power of a trial to detect small treatment effects.<br><br>Many studies have attempted classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and Lellouch1 created an approach to distinguish between explanatory trials that confirm the clinical or physiological hypothesis as well as pragmatic trials that aid in the selection of appropriate treatments in the real-world clinical setting. The framework consisted of nine domains scored on a 1-5 scale which indicated that 1 was more explanatory while 5 was more pragmatic. The domains included recruitment and setting up, the delivery of intervention, flexible adherence and primary analysis.<br><br>The initial PRECIS tool3 had similar domains and an assessment scale ranging from 1 to 5. Koppenaal and colleagues10 developed an adaptation to this assessment dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic systematic reviews had a higher average score in most domains but lower scores in the primary analysis domain.<br><br>This distinction in the main analysis domain could be explained by the fact that the majority of pragmatic trials analyse their data in the intention to treat way, whereas some explanatory trials do not. The overall score was lower for pragmatic systematic reviews when the domains of organisation, flexible delivery and follow-up were combined.<br><br>It is important to remember that a pragmatic study does not necessarily mean a low-quality study. In fact, there is an increasing number of clinical trials that use the term "pragmatic" either in their title or abstract (as defined by MEDLINE but which is neither sensitive nor precise). The use of these terms in abstracts and titles could suggest a greater awareness of the importance of pragmatism but it is unclear whether this is manifested in the content of the articles.<br><br>Conclusions<br><br>As the importance of real-world evidence becomes increasingly widespread the pragmatic trial has gained popularity in research. They are randomized trials that compare real world alternatives to new treatments that are being developed. They involve patient populations closer to those treated in regular care. This method is able to overcome the limitations of observational research, for example, the biases that are associated with the reliance on volunteers, as well as the insufficient availability and the coding differences in national registry.<br><br>Pragmatic trials have other advantages, including the ability to use existing data sources and a higher chance of detecting significant differences from traditional trials. However, pragmatic tests may still have limitations which undermine their validity and generalizability. For example, participation rates in some trials may be lower than expected due to the healthy-volunteer effect as well as incentives to pay or compete for [https://bookmark-share.com/story18348730/25-shocking-facts-about-pragmatic-casino 프라그마틱 슬롯 추천] participants from other research studies (e.g., industry trials). The necessity to recruit people in a timely fashion also limits the sample size and impact of many pragmatic trials. Some pragmatic trials also lack controls to ensure that any observed differences aren't due to biases in the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described themselves as pragmatic. The PRECIS-2 tool was employed to evaluate the pragmatism of these trials. It includes areas like eligibility criteria and flexibility in recruitment and adherence to intervention and follow-up. They discovered that 14 of these trials scored highly or pragmatic pragmatic (i.e. scoring 5 or higher) in one or more of these domains, and that the majority of them were single-center.<br><br>Trials with a high pragmatism score tend to have broader eligibility criteria than traditional RCTs which have very specific criteria that aren't likely to be present in the clinical setting, and include populations from a wide range of hospitals. The authors argue that these traits can make pragmatic trials more meaningful and relevant to daily practice, but they do not necessarily guarantee that a trial using a pragmatic approach is free from bias. The pragmatism characteristic is not a definite characteristic; a pragmatic test that doesn't have all the characteristics of an explanation study may still yield valuable and valid results.

Latest revision as of 08:14, 27 December 2024

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a free and non-commercial open data platform and infrastructure that supports research on pragmatic trials. It collects and distributes cleaned trial data, 프라그마틱 사이트 슬롯, mouse click the up coming internet site, ratings and evaluations using PRECIS-2. This allows for diverse meta-epidemiological analyses that compare treatment effect estimates across trials of different levels of pragmatism.

Background

Pragmatic studies provide real-world evidence that can be used to make clinical decisions. However, the use of the term "pragmatic" is not consistent and its definition and assessment requires further clarification. Pragmatic trials must be designed to guide clinical practice and policy decisions, rather than confirm a physiological or clinical hypothesis. A pragmatic trial should aim to be as close as is possible to the real-world clinical practice which include the recruitment of participants, setting, designing, delivery and execution of interventions, determining and analysis results, as well as primary analysis. This is a significant difference between explanation-based trials, as defined by Schwartz and Lellouch1 which are designed to confirm a hypothesis in a more thorough way.

Trials that are truly practical should not attempt to blind participants or the clinicians, as this may lead to bias in estimates of treatment effects. The trials that are pragmatic should also try to enroll patients from a wide range of health care settings, so that their results can be applied to the real world.

Finally the focus of pragmatic trials should be on outcomes that are important to patients, such as quality of life or functional recovery. This is particularly relevant when trials involve surgical procedures that are invasive or may have harmful adverse consequences. The CRASH trial29, for instance was focused on functional outcomes to compare a two-page report with an electronic system for the monitoring of hospitalized patients with chronic heart failure. In addition, the catheter trial28 focused on urinary tract infections that are symptomatic of catheters as its primary outcome.

In addition to these characteristics, pragmatic trials should minimize the trial procedures and data collection requirements in order to reduce costs. Additionally, pragmatic trials should aim to make their results as applicable to current clinical practices as they can. This can be achieved by ensuring that their analysis is based on the intention to treat method (as described within CONSORT extensions).

Many RCTs that do not meet the criteria for pragmatism but contain features contrary to pragmatism, have been published in journals of different types and incorrectly labeled pragmatic. This can lead to false claims of pragmatism, and the usage of the term should be standardized. The creation of the PRECIS-2 tool, which offers an objective and standard assessment of pragmatic features, is a good first step.

Methods

In a practical trial the goal is to inform policy or clinical decisions by demonstrating how the intervention can be implemented into routine care. Explanatory trials test hypotheses about the causal-effect relationship in idealized settings. In this way, pragmatic trials may have a lower internal validity than studies that explain and be more susceptible to biases in their design, analysis, and conduct. Despite these limitations, pragmatic trials can be a valuable source of information for decision-making in the context of healthcare.

The PRECIS-2 tool scores an RCT on 9 domains, ranging between 1 and 5 (very pragmatist). In this study, the domains of recruitment, organisation, flexibility in delivery, flexibility in adherence, and follow-up scored high. However, the main outcome and the method of missing data was scored below the pragmatic limit. This suggests that a trial could be designed with effective practical features, but without harming the quality of the trial.

However, it's difficult to judge how practical a particular trial is, since the pragmatism score is not a binary quality; certain aspects of a trial may be more pragmatic than others. Furthermore, logistical or protocol modifications made during a trial can change its score on pragmatism. Additionally 36% of 89 pragmatic trials discovered by Koppenaal and colleagues were placebo-controlled or conducted prior to approval and a majority of them were single-center. They are not in line with the usual practice and are only called pragmatic if their sponsors agree that the trials aren't blinded.

Another common aspect of pragmatic trials is that the researchers attempt to make their findings more meaningful by analysing subgroups of the sample. However, 프라그마틱 슬롯체험 this often leads to unbalanced comparisons and lower statistical power, increasing the likelihood of missing or misinterpreting the results of the primary outcome. This was the case in the meta-analysis of pragmatic trials due to the fact that secondary outcomes were not corrected for differences in covariates at the baseline.

Additionally, studies that are pragmatic can pose difficulties in the collection and interpretation of safety data. This is due to the fact that adverse events are typically reported by participants themselves and prone to reporting errors, delays or coding deviations. It is essential to increase the accuracy and quality of outcomes in these trials.

Results

While the definition of pragmatism does not mean that trials must be 100% pragmatic, there are some advantages to incorporating pragmatic components into clinical trials. These include:

Enhancing sensitivity to issues in the real world as well as reducing the size of studies and their costs and allowing the study results to be more quickly translated into actual clinical practice (by including patients from routine care). However, pragmatic trials have their disadvantages. The right amount of heterogeneity for instance could allow a study to expand its findings to different patients or settings. However the wrong type of heterogeneity could reduce the sensitivity of an assay and thus lessen the power of a trial to detect small treatment effects.

Many studies have attempted classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and Lellouch1 created an approach to distinguish between explanatory trials that confirm the clinical or physiological hypothesis as well as pragmatic trials that aid in the selection of appropriate treatments in the real-world clinical setting. The framework consisted of nine domains scored on a 1-5 scale which indicated that 1 was more explanatory while 5 was more pragmatic. The domains included recruitment and setting up, the delivery of intervention, flexible adherence and primary analysis.

The initial PRECIS tool3 had similar domains and an assessment scale ranging from 1 to 5. Koppenaal and colleagues10 developed an adaptation to this assessment dubbed the Pragmascope that was simpler to use in systematic reviews. They found that pragmatic systematic reviews had a higher average score in most domains but lower scores in the primary analysis domain.

This distinction in the main analysis domain could be explained by the fact that the majority of pragmatic trials analyse their data in the intention to treat way, whereas some explanatory trials do not. The overall score was lower for pragmatic systematic reviews when the domains of organisation, flexible delivery and follow-up were combined.

It is important to remember that a pragmatic study does not necessarily mean a low-quality study. In fact, there is an increasing number of clinical trials that use the term "pragmatic" either in their title or abstract (as defined by MEDLINE but which is neither sensitive nor precise). The use of these terms in abstracts and titles could suggest a greater awareness of the importance of pragmatism but it is unclear whether this is manifested in the content of the articles.

Conclusions

As the importance of real-world evidence becomes increasingly widespread the pragmatic trial has gained popularity in research. They are randomized trials that compare real world alternatives to new treatments that are being developed. They involve patient populations closer to those treated in regular care. This method is able to overcome the limitations of observational research, for example, the biases that are associated with the reliance on volunteers, as well as the insufficient availability and the coding differences in national registry.

Pragmatic trials have other advantages, including the ability to use existing data sources and a higher chance of detecting significant differences from traditional trials. However, pragmatic tests may still have limitations which undermine their validity and generalizability. For example, participation rates in some trials may be lower than expected due to the healthy-volunteer effect as well as incentives to pay or compete for 프라그마틱 슬롯 추천 participants from other research studies (e.g., industry trials). The necessity to recruit people in a timely fashion also limits the sample size and impact of many pragmatic trials. Some pragmatic trials also lack controls to ensure that any observed differences aren't due to biases in the trial.

The authors of the Pragmatic Free Trial Meta identified RCTs published up to 2022 that self-described themselves as pragmatic. The PRECIS-2 tool was employed to evaluate the pragmatism of these trials. It includes areas like eligibility criteria and flexibility in recruitment and adherence to intervention and follow-up. They discovered that 14 of these trials scored highly or pragmatic pragmatic (i.e. scoring 5 or higher) in one or more of these domains, and that the majority of them were single-center.

Trials with a high pragmatism score tend to have broader eligibility criteria than traditional RCTs which have very specific criteria that aren't likely to be present in the clinical setting, and include populations from a wide range of hospitals. The authors argue that these traits can make pragmatic trials more meaningful and relevant to daily practice, but they do not necessarily guarantee that a trial using a pragmatic approach is free from bias. The pragmatism characteristic is not a definite characteristic; a pragmatic test that doesn't have all the characteristics of an explanation study may still yield valuable and valid results.